Sandoz is a global pharmaceutical company and the leader in generic and biosimilar medicines. The company specializes in developing and providing high-quality, affordable versions of off-patent medicines, pioneering access for patients worldwide. Its portfolio comprises approximately 1,300 products across multiple therapeutic areas, including cardiovascular, metabolism, oncology, immunology, and anti-infectives.
A key part of its business is antibiotics, where it supplies more than 50 different products worldwide, many of which are included on the WHO Essential Medicines List. Sandoz has a history spanning over 135 years and sells its products in more than 100 countries. In October 2023, it completed a spin-off from Novartis to become an independent, publicly traded company.
